Dihydroartemisinin 13CD4

STABLE ISOTOPES

Product Details

CAT No.# CS-O-33336
Category Stable Isotopes
CAS 71939-50-9 (Unlabeled)
Molecular Weight 289.37
Molecular Formula C1413CH20D4O5
Purity: >98
Synonyms: [3R-​(3α,​5aβ,​6β,​8aβ,​9α,​10α,​12β,​12aR*)​]​- decahydro-​10-d-3,​6-​dimethyl-​9-​(methyl-​13Cd3)​-​3,​12-​Epoxy-​12H-​pyrano[4,​3-​j]​-​1,​2-​benzodioxepin-​10-​ol
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. Lisinopril EP Impurity I
2. Nomegestrol acetate impurity A
3. 7-oxo-hyocholicacid (7-OXO-HCA)
4. Dehydrochenodeoxycholic Acid
5. 7-Oxoisolithocholic acid
6. Hyocholic acid methyl ester
7. 7-Oxo hyocholic acid methyl ester
8. Chenodeoxycholic Acid Methyl Ester
9. 5beta-Cholanic acid 3,7-dione methyl ester
10. (R)-methyl 4-((5R,8R,9S,10S,13R,14S,17R)-3,3-dimethoxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
11. methyl (4R)-4-((3R,5S,8S,9S,10R,13R,14S,17R)-3-hydroxy-6-(1-hydroxyethyl)-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
12. (R)-4-((3R,5R,8S,9S,10R,13R,14S,17R)-6-ethylidene-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
13. methyl (R)-4-((5R,8S,9S,10R,13R,14S,17R)-6-ethylidene-10,13-dimethyl-3,7-dioxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
14. Hyocholic Acid Methyl ester acetal
15. methyl sulfate
16. Titanium(IV) bromide
17. 4-isobutoxy benzylamine
18. 2-(phenylthio)phenyl phenylcarbamate
19. BDE No 28 solution
20. methyl (R)-4-((3R,5R,8S,9S,10R,13R,14S,17R)-6-ethylidene-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate


SMILES:
O[C@]1([2H])[C@@H]([C@@](CC[C@@H](C)[C@]2([H])CC[C@]3(C)O4)([H])[C@@]2(OO3)[C@]4([H])O1)[13C]([2H])([2H])[2H]



This page contains information about Dihydroartemisinin 13CD4 Cas 71939-50-9 (Unlabeled) and its Stable Isotopes.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."